ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Garb’s Questions, Answers About Cancer Program

December 5, 1980

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says

January 20, 1995

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980

NCI Seeks Nominations For Consumer Liaison Group.

November 23, 2001

SEER Program Expansion Through Cost-Sharing.

March 23, 2001